Huntington Disease
📧 Sign up to get email alerts when something new happens for Huntington Disease.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2025-11-18Clinical Trial Update: Efficacy of Cognitive Rehabilitation Using Virtual Reality and Computer-based Cognitive Stimulation on Cognitive Impairment Associated to Movement Disorders [NA]
A completed clinical trial evaluated the efficacy of virtual reality–based cognitive rehabilitation combined with computer-based cognitive s…
-
CLINICAL_TRIALS trial_result · 2025-11-18Clinical Trial Update: Dance and Huntington Disease [NA]
This entry notes the completion of a clinical trial investigating dance therapy for Huntington's disease. The brief update does not provide …
-
CLINICAL_TRIALS trial_result · 2025-10-21Clinical Trial Update: Safety and Proof-of-Concept (POC) Study With AMT-130 in Adults With Early Manifest Huntington's Disease [Phase 1, Phase 2]
This is a status update on a safety and proof-of-concept study of AMT-130 in adults with early manifest Huntington's disease, with the trial…
-
CLINICAL_TRIALS trial_result · 2025-09-25Clinical Trial Update: TEsting METformin Against Cognitive Decline in HD [Phase 3]
A Phase 3 trial evaluating metformin for cognitive decline in Huntington's disease has completed.
-
CLINICAL_TRIALS trial_result · 2025-09-19Clinical Trial Update: Dose-response Evaluation of the Cellavita HD Product in Patients With Huntington's Disease [Phase 2]
Phase 2 dose-response study evaluating Cellavita HD in Huntington disease has completed with results posted.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS research · 2025-09-18Clinical Trial Update: A Study to Evaluate AB-1001 Striatal Administration in Adults With Early Manifest Huntington's Disease [Phase 1, Phase 2]
A Phase 1/2 clinical trial evaluating AB-1001 Striatal Administration for Huntington's disease is ongoing but not currently recruiting.
-
CLINICAL_TRIALS trial_result · 2025-09-17Clinical Trial Update: A Study to Evaluate Safety, Tolerability, and Pharmacokinetics of SAGE-718 Oral Solution in Patients With Huntington's Disease - Part B [Phase 1]
This is a completed Phase 1 study evaluating the safety, tolerability, and pharmacokinetics of SAGE-718 oral solution in patients with Hunti…
-
CLINICAL_TRIALS research · 2025-09-10Clinical Trial Update: Longitudinal Endpoint Assessment of Disease Burden in HD
A Huntington disease clinical trial is currently recruiting to longitudinally assess disease burden endpoints.
-
CLINICAL_TRIALS trial_result · 2025-09-05Clinical Trial Update: A Study to Evaluate the Effect of SAGE-718 on Cognitive Function in Participants With Huntington's Disease (HD) [Phase 2]
A Phase 2 clinical trial evaluating SAGE-718 for cognitive function in Huntington's disease has completed and results have been posted.
-
CLINICAL_TRIALS trial_result · 2025-08-28Clinical Trial Update: Efficacy and Safety on SOM3355 in Huntington's Disease Chorea [Phase 2]
A Phase 2 trial evaluating the efficacy and safety of SOM3355 in Huntington's disease chorea has completed, with results posted.
-
CLINICAL_TRIALS other · 2025-08-28Clinical Trial Update: A Safety and Pharmacokinetics Trial of VO659 in SCA1, SCA3 and HD [Phase 1, Phase 2]
This document reports a Phase 1/2 safety and pharmacokinetics trial of VO659 in Spinocerebellar ataxia type 1, spinocerebellar ataxia type 3…
-
CLINICAL_TRIALS trial_result · 2025-08-27Clinical Trial Update: 31P-MRS and Huntington Disease [NA]
A completed clinical trial investigated phosphorus-31 magnetic resonance spectroscopy (31P-MRS) in individuals with Huntington's disease, sp…
-
CLINICAL_TRIALS research · 2025-08-22Clinical Trial Update: Gait Analysis Parameter and Upper Limb Evaluation in Adult Patients With Neurological or Metabolic Pathology [NA]
This clinical trial update describes the assessment of gait analysis parameters and upper-limb evaluation in adults with various neurologica…
-
CLINICAL_TRIALS trial_result · 2025-08-12Clinical Trial Update: Study of WVE-003 in Patients With Huntington's Disease [Phase 1, Phase 2]
Phase 1/2 study of WVE-003 in Huntington's disease has completed and results have been posted.
-
CLINICAL_TRIALS research · 2025-07-30Clinical Trial Update: Move to Improve: Telehealth Exercise to Music for HD [NA]
This update reports that the Telehealth Exercise to Music for Huntington disease trial has completed. The study was sponsored by Ohio State …
-
CLINICAL_TRIALS research · 2025-07-30Clinical Trial Update: Comparison Between [11C]UCB-J and [18F]SynVest-1 PET in HD. [NA]
This ClinicalTrials.gov update shows Huntington disease research recruiting participants to compare two PET tracers, [11C]UCB-J and [18F]Syn…
-
CLINICAL_TRIALS research · 2025-07-08Clinical Trial Update: Promoting Goals-of-Care Discussions for Patients With Memory Problems and Their Caregivers [NA]
The clinical trial update shows that the University of Washington is recruiting for a study intended to promote goals-of-care discussions fo…
-
CLINICAL_TRIALS research · 2025-06-18Clinical Trial Update: Gut Microbiomes in HD
A clinical trial exploring gut microbiomes in Huntington disease is currently recruiting.
-
CLINICAL_TRIALS research · 2025-06-08Clinical Trial Update: Gait Analysis in Neurological Disease
A clinical trial update indicates recruitment for gait analysis in Parkinson's-related and other neurological gait disorders, aiming to stud…
-
CLINICAL_TRIALS research · 2025-06-04Clinical Trial Update: Time-Restricted Eating in Huntington's Disease: A Clinical Pilot Study [NA]
A clinical pilot study evaluating time-restricted eating as a potential intervention for Huntington disease has completed.
-
CLINICAL_TRIALS trial_result · 2025-05-28Clinical Trial Update: Effect of Tetrabenazine on Stroop Interference in HD [Phase 4]
Phase 4 trial evaluating the effect of tetrabenazine on Stroop interference in Huntington disease has completed and results have been posted…
-
FDA approval · 2025-05-18FDA Approved: TETRABENAZINE — Supplemental Application (Sun Pharmaceutical Industries, Inc.)
FDA approved Sun Pharmaceutical Industries, Inc.'s supplemental application for tetrabenazine, updating the approval/ labeling for this gene…
-
CLINICAL_TRIALS trial_result · 2025-05-16Clinical Trial Update: Transcranial Static Magnetic Stimulation (tSMS) in Huntington's Disease (HD) [NA]
This clinical trial update concerns the use of transcranial static magnetic stimulation (tSMS) for Huntington's disease. The study is curren…
-
CLINICAL_TRIALS trial_result · 2025-05-16Clinical Trial Update: Couple and Spouse Caregiver in Huntington's Disease
A clinical trial evaluating care for couples and spouses of individuals with Huntington's disease has been terminated.
-
CLINICAL_TRIALS trial_result · 2025-05-06Clinical Trial Update: 28-Day Study of SAGE-718 on Functioning Capacity in Participants With Huntington's Disease [Phase 2]
Phase 2 trial of SAGE-718 in Huntington's disease completed; results have been posted.